- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Indolent B-Cell Non-Hodgkin Lymphoma in New Zealand
Total 1397 results
-
Gilead SciencesCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaUnited States
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Alexion PharmaceuticalsPortola PharmaceuticalsCompletedFollicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)United States
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Kite, A Gilead CompanyActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-Hodgkin LymphomaUnited States, France
-
SecuraBioWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
SynthekineRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | NHL | CLL/SLL | Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous... and other conditionsUnited States
-
Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Non-FL Indolent Non-Hodgkin's LymphomaUnited States, Canada
-
Alopexx Oncology, LLCTerminatedB-cell Non-Hodgkin LymphomaUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Alopexx Oncology, LLCTerminatedB-cell Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
Cellectis S.A.RecruitingB-cell Non-Hodgkin Lymphoma (B-NHL)United States, Spain, France
-
Aegera TherapeuticsThe Leukemia and Lymphoma SocietyTerminatedLymphoma, B-Cell | Leukemia, Lymphocytic, Chronic, B-CellCanada, United States
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
SanofiCompletedLymphoma | Non-HodgkinUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
TG Therapeutics, Inc.CompletedB-cell Lymphoma | Marginal Zone Lymphoma | Primary Central Nervous System Lymphoma | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
TG Therapeutics, Inc.CompletedWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Non Follicular Indolent Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditionsUnited States
-
Gilead SciencesTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterNot yet recruitingHIV Infection | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)United States, Canada
-
Lars Møller PedersenZealand University Hospital; Weill Medical College of Cornell University; Herlev... and other collaboratorsRecruitingDiffuse Large B Cell LymphomaDenmark
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Novartis PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (B-NHL) | B-cell Acute Lymphoblastic Leukemia (B-ALL)Japan, Italy, Spain, Belgium, Singapore, France, United States, Israel
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Non-Hodgkin's LymphomaHong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingB-Cell Lymphoma | B-cell Non Hodgkin Lymphoma | B Cell ALLUnited States
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkins Lymphoma (B-NHL)United States, Spain, United Kingdom, Netherlands
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaUnited States, Australia
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Taiwan, Australia
-
Eisai Inc.CompletedLymphoma, B-CellUnited States
-
Sutro Biopharma, Inc.Active, not recruitingFollicular Lymphoma | B-cell Lymphoma | Multiple Myeloma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Indolent Lymphoma | B Cells--TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of California... and other collaboratorsActive, not recruitingHodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany